Fully Automated High-Throughput Quantitative MRI of the Liver
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorUniversity of Wisconsin, Madison
About this trial
The purpose of this research is to see if a new automated magnetic resonance imaging (MRI) method will be able to improve the images taken of the liver. Participants will have either known or suspected liver disease, known or suspected iron overload syndrome, or be a healthy adult. Participants will be in the research study for one day.
Eligibility criteria
Qualifiers
Age 18 years or older
Disqualifiers
Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)
Age 7 years or older
Known or suspected liver iron overload
Trial design
Treatments tested in this trial
- Non-contrast MRI with novel MRI software
Treatment groups
200 Participants
are divided into 4 treatment groupsLocations
1University of Wisconsin53705, MadisonWisconsin, United States
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator
Source ClinicalTrials.gov